Michael R. Kennedy

发表

MAGTF Area of Operations: Turf War or Doctrinal Necessity?

Michael R. Kennedy, 2002 .

A Potential Role for 5‐Androstene‐3β,7β,17β‐triol in Obesity and Metabolic Syndrome

Michael R. Kennedy, C. Ahlem, J. Frincke, 2011, Obesity.

Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis.

Michael R. Kennedy, H. Sasano, Yasuhiro Nakamura, 2009, The Journal of clinical endocrinology and metabolism.

Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome

Michael R. Kennedy, A. Garsd, J. Groothuis, 2010, Journal of radiological protection : official journal of the Society for Radiological Protection.

The effects of ACTH on steroid metabolomic profiles in human adrenal cells.

Michael R. Kennedy, C. Gomez-Sanchez, W. Rainey, 2011, The Journal of endocrinology.

Liquid chromatography–tandem mass spectrometry analysis of human adrenal vein corticosteroids before and after adrenocorticotropic hormone stimulation

Michael R. Kennedy, H. Sasano, Yasuhiro Nakamura, 2012, Clinical endocrinology.

Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.

Yasuhiro Nakamura, Hironobu Sasano, Ryo Morimoto, 2013, The Journal of clinical endocrinology and metabolism.

Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.

Michael R. Kennedy, C. Ahlem, J. Frincke, 2011, International journal of clinical and experimental medicine.

Pharmacology and immune modulating properties of 5-androstene-3β,7β,17β-triol, a DHEA metabolite in the human metabolome

Michael R. Kennedy, R. Pieters, F. Nicoletti, 2011, The Journal of Steroid Biochemistry and Molecular Biology.

Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols

Michael R. Kennedy, F. Nicoletti, K. Mangano, 2011, Steroids.

Azetidine-based selective glycine transporter-1 (GlyT1) inhibitors with memory enhancing properties.

Michael R. Kennedy, Kiev S. Ly, Marco Peters, 2020, Bioorganic & medicinal chemistry letters.

17α-Alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism

Michael R. Kennedy, C. Ahlem, J. Frincke, 2012, Investigational New Drugs.

Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.

Michael R. Kennedy, Kiev S. Ly, D. M. Chung, 2018, Journal of medicinal chemistry.